Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Enterprise Value (2016 - 2025)

Avricore Health has reported Enterprise Value over the past 12 years, most recently at -$812022.8 for Q4 2025.

  • Quarterly Enterprise Value changed 0.17% to -$812022.8 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$812022.8 through Dec 2025, changed 0.17% year-over-year, with the annual reading at -$810477.2 for FY2025, 2.01% up from the prior year.
  • Enterprise Value was -$812022.8 for Q4 2025 at Avricore Health, down from -$386389.6 in the prior quarter.
  • Over five years, Enterprise Value peaked at -$202212.3 in Q2 2024 and troughed at -$2.1 million in Q2 2021.
  • The 5-year median for Enterprise Value is -$799902.2 (2024), against an average of -$925824.7.
  • Year-over-year, Enterprise Value crashed 5477.08% in 2021 and then soared 75.19% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$1.8 million in 2021, then soared by 75.19% to -$457144.1 in 2022, then rose by 0.29% to -$455799.1 in 2023, then crashed by 77.85% to -$810621.8 in 2024, then dropped by 0.17% to -$812022.8 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Enterprise Value are -$812022.8 (Q4 2025), -$386389.6 (Q3 2025), and -$817261.5 (Q2 2025).